Treatment by oral creatine, L‐arginine and L‐glycine in six severely affected patients with creatine transporter defect
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: X‐linked cerebral creatine deficiency is caused by the deficiency of the creatine transporter (CTP) encoded by the SLC6A8 gene. Patients and Methods: We report here a series of six patients with severe CTP deficiency, four males and two females; clinical presentations include mild to severe mental retardation (6/6), associated with psychiatric symptoms (5/6: autistic behaviour, chronic hallucinatory psychosis), seizures (2/6) and muscular symptoms (2/4 males). Diagnosis was suspected upon elevated urinary creatine/creatinine (except in one of the female patients) and on a markedly decreased creatine peak on magnetic resonance spectroscopy (MRS). Diagnosis was confirmed by molecular analysis that identified four novel mutations not reported so far, including a mutation found twice in two male patients. All patients were treated successively and according to the same protocol by creatine alone then combined to its precursors, L‐glycine and L‐arginine for 42 months. Results and conclusion: In our patients, creatine supplementation alone or with its precursors L‐glycine and L‐arginine showed benefit only in the muscular symptoms of the disease and no improvement in the cognitive and psychiatric manifestations and did not modify brain creatine content on MRS of male and female CTP deficient patients. New treatment strategies are required including creatine derivatives transported independently from CTP or using alternative pathways and transporters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerebral creatine deficiency syndromes: Clinical aspects, treatment and pathophysiology
Stockler, S., Schutz, P. W., & Salomons, G. S. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_8 · Cited by 180
Battini, R., Alessandrì, M. G., Leuzzi, V., Moro, F., Tosetti, M., Bianchi, M. C., & Cioni, G. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.01.043 · Cited by 101 · cited 1×
“In a few patients early treatment in asymptomatic patients totally prevented the occurrence of clinical manifestations (Battini et al. 2006).”
BackgroundDissociation of AGAT, GAMT and SLC6A8 in CNS: Relevance to creatine deficiency syndromes
Braissant, O., Béard, E., Torrent, C., & Henry, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.022 · Cited by 94 · cited 1×
“Indeed, recent data suggest that AGAT and GAMTare rarely co-expressed in one cell and the Cr transporter may be needed for GAA uptake from AGAT- to GAMT-expressing cells (Braissant et al. 2010).”
Background
Cited by
Rae, C. D. (2014) · Neurochemical Research · doi:10.1007/s11064-013-1199-5 · Cited by 496
Creatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
Self-citationPhenotype and genotype in 101 males with X-linked creatine transporter deficiency
van de Kamp, J. M., Betsalel, O. T., Mercimek-Mahmutoglu, S., Abulhoul, L., Grünewald, S., Anselm, I., Azzouz, H., Bratkovic, D., de Brouwer, A., Hamel, B., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101658 · Cited by 164
Self-citationCreatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Braissant, O. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9433-2 · Cited by 112
“With the exception of SLC6A8deficient heterozygous females where brain Cr deficiency is often partial (Cecil et al. 2003; Valayannopoulos et al. 2011; van de Kamp et al. 2011a), the common phenotype of these three primary Cr deficiencies is the virtual absence of the Cr peak measured by magnetic…”
BackgroundResultInfluentialBeyond muscles: The untapped potential of creatine
Riesberg, L. A., Weed, S. A., McDonald, T. L., Eckerson, J. M., & Drescher, K. M. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.034 · Cited by 95
Metadata
- Authors
- Valayannopoulos, V., Boddaert, N., Chabli, A., Barbier, V., Desguerre, I., Philippe, A., Afenjar, A., Mazzuca, M., Cheillan, D., Munnich, A., de Keyzer, Y., Jakobs, C., Salomons, G. S., & de Lonlay, P.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2011-06-10
- Volume
- 35
- Issue
- 1
- Pages
- 151-157
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2043791129
- Cited by
- 69
- References
- 3
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment by oral creatine, L‐arginine and L‐glycine in six severely affected patients with creatine transporter defect. https://app.cochat.ai/papers/10.1007/s10545-011-9358-9
- The paper
- Valayannopoulos, V., Boddaert, N., Chabli, A., Barbier, V., Desguerre, I., Philippe, A., Afenjar, A., Mazzuca, M., Cheillan, D., Munnich, A., de Keyzer, Y., Jakobs, C., Salomons, G. S., & de Lonlay, P. (2012). Treatment by oral creatine, L‐arginine and L‐glycine in six severely affected patients with creatine transporter defect. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-011-9358-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.